NEW YORK (GenomeWeb News) - NextGen Sciences said today that it will now offer protein biomarker services, including assay development and validation, and that it has named Mike Pisano, the former head of Protein Research Services, to be CEO of the company.
 
NextGen said its biomarker services are supported by the proteomics know-how that it acquired when it bought PRS in 2006, and by its investments into technologies such as ThermoFisher’s OrbiTrap and its triple quad mass spectrometers.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.